Showing results (181-190 of 445) with videos related to

Sort By:
Pageof 45
Nephron. Clinical Practice|September 25, 2007
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) studyDaniel Zehnder, Martin J Landray, David C Wheeler, et al.
Environmental Health Perspectives|March 10, 2015
Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL StudyJenna Czarnota, Chris Gennings, Joanne S Colt, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) studyMartin J Landray, David C Wheeler, Gregory Y H Lip, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2020
Estradiol and mortality in women with end-stage kidney diseaseSharanya Ramesh, Matthew T James, Jayna M Holroyd-Leduc, et al.
Journal of the National Cancer Institute|August 8, 2024
Ambient ultraviolet A, ultraviolet B, and risk of melanoma in a nationwide United States cohort, 1984-2014Elizabeth K Cahoon, Soutrik Mandal, Ruth M Pfeiffer, et al.
BMJ Open|February 22, 2024
Randomised, blinded, cross-over evaluation of the palatability of and preference for different potassium binders in participants with chronic hyperkalaemia in the USA, Canada and Europe: the APPETIZE studyDavid C Wheeler, Henning Søndergaard, Cathy Gwynn, et al.
Childhood Obesity (Print)|July 3, 2024
The Association Between a Neighborhood Adverse Childhood Experiences Index and Body Mass Index Among New York City YouthKrista Schroeder, Levent Dumenci, Sophia E Day, et al.
Kidney International|December 18, 2009
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conferenceNathan W Levin, Peter Kotanko, Kai-Uwe Eckardt, et al.
Clinical Kidney Journal|February 23, 2024
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trialPhil McEwan, Jason A Davis, Peter D Gabb, et al.
American Journal of Nephrology|April 10, 2026
Potentially modifiable factors associated with longitudinal health-related quality of life in the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohortThomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, et al.
Pageof 45